Zentalis Pharmaceuticals (ZNTL) Ratings: Wedbush & TD Cowen Weigh In
Investors are weighing mixed signals for Zentalis Pharmaceuticals (NASDAQ: ZNTL) as analysts adjust their outlooks on the biopharmaceutical company. Wedbush maintained a Hold rating on the … Read more